MORTEZA MASHKOURI

Allopathic & Osteopathic Physicians|Family Medicine CASSELBERRY, FL NPI 1023094489

General Payments — all program years on this page

$727.27

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 39
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $413.23 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $413.2320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $74.344
2020 $27.672
2021 $76.855
2022 $115.737
2023 $19.451
2024 $413.2320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086207945 Bayer Healthcare Pharmaceuticals Inc. $32.73 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086251638 Bayer Healthcare Pharmaceuticals Inc. $29.46 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096943466 Novo Nordisk Inc $19.94 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104644621 AstraZeneca Pharmaceuticals LP $14.62 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104661567 AstraZeneca Pharmaceuticals LP $22.51 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104766634 AstraZeneca Pharmaceuticals LP $20.66 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104772880 AstraZeneca Pharmaceuticals LP $13.42 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105229372 AstraZeneca Pharmaceuticals LP $20.87 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105434770 AstraZeneca Pharmaceuticals LP $25.68 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105490315 AstraZeneca Pharmaceuticals LP $17.50 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115764152 GlaxoSmithKline, LLC. $21.25 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116522364 GlaxoSmithKline, LLC. $20.99 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117621682 Amgen Inc. $14.05 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117840461 Boehringer Ingelheim Pharmaceuticals, Inc. $15.63 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117840463 Boehringer Ingelheim Pharmaceuticals, Inc. $16.80 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117840465 Boehringer Ingelheim Pharmaceuticals, Inc. $21.71 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117840467 Boehringer Ingelheim Pharmaceuticals, Inc. $22.40 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117840469 Boehringer Ingelheim Pharmaceuticals, Inc. $24.34 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118937202 Otsuka America Pharmaceutical, Inc. $23.38 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118937204 Otsuka America Pharmaceutical, Inc. $15.29 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.